Vera Therapeutics, Inc. Class A Share Price
NASDAQ: VERA | Small CapVera Therapeutics, Inc. Class A Stock Performance
Vera Therapeutics, Inc. Class A Share Price Today
As of 30 October 2026, Vera Therapeutics, Inc. Class A's share price is $30.80. The stock opened at $31.30, compared to its previous close of $30.88. During today's trading session, Vera Therapeutics, Inc. Class A's share price traded between $30.80 and $31.87, with an average price of $31.34. Over the past 52 weeks, the stock has recorded a high of $56.01 and a low of $23.18. In terms of performance, Vera Therapeutics, Inc. Class A's share price has declined by 13.49% over the last six months and is up 8.37% on a year-on-year basis.
Vera Therapeutics, Inc. Class A Share Price Chart
Vera Therapeutics, Inc. Class A Quarterly Profit & Loss
All figures in USD
Vera Therapeutics, Inc. Class A Annual Profit & Loss
All figures in USD
About Vera Therapeutics, Inc. Class A
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
Vera Therapeutics, Inc. Class A Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $32.14 | $30.87 | -4.60% |
Sep 2026 | $34.09 | $32.36 | -6.42% |
Aug 2026 | $31.41 | $34.58 | +7.76% |
Jul 2026 | $42.75 | $32.09 | -25.25% |
Jun 2026 | $34.70 | $42.93 | +20.78% |
May 2026 | $34.79 | $35.55 | -0.18% |
Apr 2026 | $41.01 | $35.61 | -11.38% |
Mar 2026 | $40.13 | $40.19 | -1.53% |
Feb 2026 | $43.29 | $40.81 | -5.65% |
Jan 2026 | $50.74 | $43.26 | -14.53% |
Dec 2025 | $33.09 | $50.61 | +49.53% |
Nov 2025 | $28.34 | $33.84 | +19.07% |